If PPHM does a REVERSE SPLIT and the SHELF REMAINS (=is not split) then BP knows they will NEVER STOP them again because PPHM will pre-fund and then AstraZeneca will be the game-breaker with Durvalumab
Planting the seed. Bad is actually good in PPHM Land. How did that last RS work out for us?
Market Data 
Markets 
AI
